Chemistry and Spectroscopy

General AMPP synthesis
AMPP was synthesized as previously described [1] and spectra matched those reported.
Peptide synthesis
Peptide synthesis was performed on a CEM Liberty 1 Peptide Synthesizer with a CEM Discovery Microwave using standard Fmoc-protected solid phase peptide synthesis protocols. Detailed information to peptide synthesis, resin, coupling reagents and conditions can be found in 1.3.
Reversed-phase HPLC
Analytical RP-HPLC was performed on Jasco devices (PU-2080 Plus, LG-2080-02-S, DG-2080-53 and MD-2010 Plus) with a Phenomenex Luna column (C18, 5 μm, 250x4.6 mm). As eluent, a water/acetonitrile gradient containing 0.1% TFA was used with a 1 mL/min flow rate. Semi-preparative RP-HPLC was performed on Jasco devices (PU-2087 Plus, LG-2080-02-S and UV-2075 Plus) with a Phenomenex Luna column (C18, 5 μm, 250x20 mm). ). The same eluent was used as for RP-HPLC, but with a 20 mL/min flow rate. NMR NMR spectra were recorded in 35% aqueous trifluoroethanol-d 3 (TFE-d 3 ) on a BRUKER Avance III HD 800 instrument and calibrated to residual solvent peaks ( 1 H/ 13 C in ppm): TFE-d 3 (3.88/126.3). To prevent thermal back relaxation during long carbon and 2D experiments, LirAzo was pre-illuminated to obtain the cisisomer and the NMR tube was equipped with a fibre optic coupled to a Polychrome V (Till Photonics) monochromator to deliver constant UV irradiation. Spectra were necessarily acquired without spinning the probe. Multiplicities are abbreviated as follows: s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet. Spectra are reported based on appearance, not on theoretical multiplicities derived from structural information.
HRMS
High-resolution electrospray ionization (ESI) mass spectra were obtained on a Varian MAT 711 MS instrument operating in either positive or negative ionization modes.
UV/Vis
UV/Vis spectra were recorded on a Varian Cary 50 Bio UV-Visible Spectrophotometer using Helma SUPRASIL precision cuvettes (10 mm light path) equipped with a Polychrome V (Till Photonics) monochromator.
CD CD measurements were recorded on a Jasco 810 instrument with a Jasco CDF-4265 Peltier-Element and Tris buffer (50 mM, pH = 7.4) as solvent. The cuvettes were of 1 mm thickness. For baseline correction, a pure buffer spectrum was recorded. Sample concentrations were calculated via the specific absorption at 323 nm, with ε azobenzene = 25,000 L mol -1 cm -1 . The recorded spectra were processed with Origin 8.0 and smoothed using a 30-point Savitzky-Golay-Filter
Peptide synthesis
A solid-phase Fmoc-Glycine-Wang LL resin (Novabiochem ® ), pre-loaded with 0.36 mmol/g amino acid, was used. The peptides were synthesized in 0.1 mmol scale with the standard coupling reagents HBTU/HOBt·H 2 O 0.5 M in DMF, activated with DIPEA 2 M in NMP. Amino acids were coupled in a tenfold excess (2 M solutions) as Fmoc-protected compounds with standard residual protecting groups. Fmoc deprotection was achieved by treatment with 20% piperidine in DMF. AMPP building blocks were coupled in a 1.5-fold excess with the coupling reagents HATU/HOAt (1.5 eq.) 0.5 M in DMF activated with NMM (5 eq.) in DMF. Coupling conditions are summarized in SI Table 1 . After coupling of all compounds, the resin-bound peptide was transferred into a Merrifield reactor followed by global deprotection with TFA/phenol/triisopropylsilane/H 2 O (88:5:2:5) solution within 2 h. The solvent was then precipitated in 180 mL chilled diethyl ether and stored overnight at -38 °C. The precipitated peptide was centrifuged and after decantation of the solution, the residue was dried and purified with RP-HPLC to yield the desired peptides.
HPLC traces of Lira and LirAzo peptides
Above are analytical HPLC traces of a) Lira and b) LirAzo using a gradient MeCN/H2O = 10/90 ! 100/0 within 40 min.
Photoswitching of LirAzo peptide
cis-/trans-Isomerization was assessed by UV/Vis spectroscopy following the π-π*-band (330 nm) and double-exponential fitting of the slopes (Wavemetrics Igor v6.2). τ-Values are given in Supplementary Table 1 
trans-LirAzo
1 H-(top) and 13 C-(bottom) NMR spectra of trans-LirAzo peptide. 
Biology
Ethical approval
All procedures involving primary tissue were regulated by the Home Office according to the Animals (Scientific Procedures) Act 1986 of the United Kingdom (PPL 70/7349).
Isolation of rodent islets
Islets were isolated from 8-12 week old female C57BL6 mice, as previously detailed, [2] and maintained in Roswell Park Memorial Institute (RPMI) medium supplemented with 10% foetal calf serum, 100 U/mL penicillin and 100 µg/mL streptomycin.
Cell lines
Chinese Hamster Ovary (CHO) cells stably expressing the GLP-1R were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% FBS, 1 x non-essential amino acids, 25 mM HEPES, 100 U/mL penicillin and 100 µg/mL streptomycin. MIN6 cells (a kind gift from Dr Jun-ichi Miyazaki, Osaka University) were cultured in DMEM supplemented with 15% FBS, 10 mM glutamine, 20 mM HEPES, 0.0005% β-mercaptoethanol 100 U/mL penicillin and 100 µg/mL streptomycin.
Cytotoxicity and apoptosis assays
Control, Lira and LirAzo-treated islets were incubated with 3 µM of calcein-AM (live) and 2.5 µM of propidium iodide (dead), and absorbance/emission detected at λ = 491/525 nm and λ = 561/620 nm, respectively. The area of dead:live cells was calculated as a ratio. Apoptosis was assessed using a DeadEnd Fluorimetric TUNEL System staining kit (Promega).
[3] The apoptotic cell mass was calculated as a fraction area versus the total cell mass. To investigate the pro-survival effects of LirAzo, MIN6 beta cells were incubated for 24 hr in a glucolipotoxic mixture (33 mM glucose + 0.5 mM palmitate) in the presence or absence of compound. Apoptosis was subsequently determined using specific fluorescent immunostaining and a rabbit polyclonal antibody against cleaved caspase 3 (Cell Signaling Technology # 9661; 1:400), before analysis as above.
Calcium imaging Multicellular Ca
2+ imaging was performed using fluo2 and a Nipkow spinning disk confocal microscope, as detailed.
[3] Briefly, pulsed λ = 491 nm light was delivered through a 10/0.3 NA objective (EC Plan-Neofluar, Zeiss) using a solid-state laser (Cobalt), and emitted signals captured from λ = 500-550 nm using a Hammamatsu ImageEM EM-CCD camera. Photoswitching was performed using either a λ = 440 nm laser or the epifluorescent port of the microscope configured with a λ = 350 ± 20 nm band-pass filter. Throughout, HEPES-bicarbonate buffer was used, containing in mM: 120 NaCl, 4.8 KCl, 24 NaHCO 3 , 0.5 Na 2 HPO 4 , 5 HEPES, 2.5 CaCl 2 and 1.2 MgCl 2 . Compounds and D-glucose were added as indicated.
cAMP and calcium assays Cellular cAMP concentrations were determined using either Cisbio HTRF cAMP or Promega cAMP-Glo assays according to the manufacturers' instructions. Treatments were applied for 5 min before cell lysis to extract cellular cAMP. High-throughput (HTS) Ca 2+ assays were performed using the DiscoverX HitHunter No Wash PLUS assay. Treatments were automatically delivered at 37 ⁰C using a BMG Labtech NOVOstar platereader and fluorescence intensity read over 30-45 s. Absorbance/emission were detected at λ = 488/525 nm. For all assays, LirAzo was preilluminated at λ = 300-340 using a UVP 3UV benchtop transilluminator to induce cis-isomerization, or kept in the dark to maintain the trans-isomer. In addition, for HTS Ca 2+ assays, λ = 340 ± 10 nm or λ = 450 ± 10 nm was delivered between acquisitions using the platereader's inbuilt multichromator.
Insulin secretion assays
Batches of six to eight islets were incubated for 30 min in Krebs-HEPESbicarbonate solution containing in mM: 130 NaCl, 3.6 KCl, 1.5 CaCl 2 , 0.5 MgSO 4 , 0.5 NaH 2 PO 4 , 2 NaHCO 3 , 10 HEPES and 0.1% (wt/vol) bovine serum albumin, pH 7.4. [2] Treatments were applied as indicated and photoswitching performed at λ = 340 ± 10 nm using a BMG Fluostar Optima platereader, as above. Insulin concentrations in the supernatant were measured using a Cisbio HTRF assay according to the low-range (sensitive) protocol.
Statistics
Non-multifactorial comparisons were made using Student's t-test. Multifactorial comparisons were made using either one-or two-way ANOVA, or the KruskalWallis test, followed by pairwise comparisons using Bonferonni's or Dunn's tests. Log-transformed concentration-response curves were fitted using non-linear regression and the Hill equation. All analyses were conducted using Graphpad Prism (Graphpad Software) and IgorPro, and results deemed significant at P<0.05. [4] served as an additional model for the design of LirAzo. GLP-1 binds to the GLP-1R ectodomain through interactions of 22 G-37 G. Moreover, the N-terminus is believed to interact with the 7TM domain located in the lipid bilayer. Therefore, we propose that replacement of 22 G-23 Q (highlighted in red) with AMPP will alter one or both of the helical interactions, leading to divergent class B GPCR signaling through isomer bias. To date, no crystal structure of the full GLP-1R is available. However, the homologous glucagon receptor (GCGR) has been resolved in atomic detail and used to model GLP-1 interactions depicting binding to the 7TM domain. [5] Taken together, a more detailed activation model can only be proposed using an x-ray structure of GLP-1R that highlights the specific interactions with the 7TM domain.
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Supplementary
Supplementary Figure 4:
CD spectral data of Lira and cis-/trans-LirAzo. a) Far UV spectra and b) Near UV spectra of Lira (black), trans-LirAzo (blue) and cisLirAzo (purple) at 50 µM and 1500 µM concentrations, respectively. Lira exhibits two minima (λ = 205 and 223 nm) and a pronounced rise to a maximum (λ = 188 nm), typical of α-helix possession. Consistent with this, both cis-/trans-LirAzo exhibit minima in the λ = 200-220 nm region. However, whereas trans-LirAzo displays a maximum at λ = 180 nm, cis-LirAzo only shows a weak maximum (λ = 189 nm) after a local minimum (λ = 193 nm), consistent with (partial) helix unfolding. Moreover, in the near UV-region, the signal of cis-LirAzo rises to a maximum (λ = 326 nm) that can be assigned to the cis-azobenzene moiety in a chiral environment. oscillations (n = 9 recordings). e-f) trans-LirAzo 150 nM is unable to properly stimulate Ca 2+ rises in the presence of low (non-permissive) glucose concentration (G3; 3 mM glucose) (G11; 11 mM glucose) (n = 5 recordings). g-h)
Supplementary
LirAzo allows photoswitching of Ca 2+ in immortalized MIN6 beta cells subjected to high-throughput assays (n = 4 repeats). Lira/LirAzo were applied at 150 nM in the presence of permissive (> 8 mM) glucose concentration. **P<0.01 versus LirAzo/Lira. Values represent mean ± S.E.M. 11 mM glucose-only), as determined using TUNEL staining (n = 8-9 islets). NS, Non-significant versus control (Con). Values represent mean ± S.E.M. 
